AnteoTech rapid test sensitive to Covid-19

Nanotechnology company AnteoTech has reported positive results from studies to assess the accuracy of its Covid-19 (SARS- CoV2) Antigen Rapid Test. The test is a disposable immunochromatographic test for the detection of SARS-CoV-2 nucleocapsid antigen in specimens, allowing the diagnosis of Covid-19 in the early stages of infection. Brisbane-based AnteoTech reported a clinical study of…

Manufacturing news briefs – stories you might have missed

AnteoTech asked for further information for Covid-19 test application Surface chemical company AnteoTech has been asked by Australia’s Therapeutic Goods Administration to supply further information on its EuGeni test reader and SARS CoV-2 Rapid Diagnostic Test (RDT). The company is one of three Australian manufacturers of RDT tests awaiting approval to sell their tests locally.…

Manufacturing news briefs – stories you might have missed

LGP to enter psychedelics market Cannabis producer Little Green Pharma has been granted a Schedule 9 licence by the Western Australian Department of Health to supply the psychedelic psilocybin to treat mental illness. LGB has established a special purpose subsidiary for psychedelic business which is planning to manufacture psilocybin in WA and conduct clinical trials.…